91 related articles for article (PubMed ID: 29883750)
21. A novel metformin derivative, HL010183, inhibits proliferation and invasion of triple-negative breast cancer cells.
Koh M; Lee JC; Min C; Moon A
Bioorg Med Chem; 2013 Apr; 21(8):2305-2313. PubMed ID: 23490148
[TBL] [Abstract][Full Text] [Related]
22. Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer.
Doddapaneni R; Patel K; Owaid IH; Singh M
Drug Deliv; 2016 May; 23(4):1232-41. PubMed ID: 26701717
[TBL] [Abstract][Full Text] [Related]
23. Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC).
Godugu C; Doddapaneni R; Singh M
Colloids Surf B Biointerfaces; 2017 May; 153():208-219. PubMed ID: 28249200
[TBL] [Abstract][Full Text] [Related]
24. A novel compound LingH2-10 inhibits the growth of triple negative breast cancer cells in vitro and in vivo as a selective inverse agonist of estrogen-related receptor α.
Ning Y; Chen H; Du Y; Ling H; Zhang L; Chen L; Qi H; Shi X; Li Q
Biomed Pharmacother; 2017 Sep; 93():913-922. PubMed ID: 28715872
[TBL] [Abstract][Full Text] [Related]
25. Preclinical activity profile and therapeutic efficacy of the HSP90 inhibitor ganetespib in triple-negative breast cancer.
Proia DA; Zhang C; Sequeira M; Jimenez JP; He S; Spector N; Shapiro GI; Tolaney S; Nagai M; Acquaviva J; Smith DL; Sang J; Bates RC; El-Hariry I
Clin Cancer Res; 2014 Jan; 20(2):413-24. PubMed ID: 24173541
[TBL] [Abstract][Full Text] [Related]
26. Ad-p53 enhances the sensitivity of triple-negative breast cancer MDA-MB-468 cells to the EGFR inhibitor gefitinib.
Wang X; Song H; Yu Q; Liu Q; Wang L; Liu Z; Yu Z
Oncol Rep; 2015 Feb; 33(2):526-32. PubMed ID: 25501339
[TBL] [Abstract][Full Text] [Related]
27. Inhibition on the growth of human MDA-MB-231 breast cancer cells in vitro and tumor growth in a mouse xenograft model by Se-containing polysaccharides from Pyracantha fortuneana.
Yuan C; Wang C; Wang J; Kumar V; Anwar F; Xiao F; Mushtaq G; Liu Y; Kamal MA; Yuan D
Nutr Res; 2016 Nov; 36(11):1243-1254. PubMed ID: 27865619
[TBL] [Abstract][Full Text] [Related]
28. Effective targeting of triple-negative breast cancer cells by PF-4942847, a novel oral inhibitor of Hsp 90.
Mehta PP; Whalen P; Baxi SM; Kung PP; Yamazaki S; Yin MJ
Clin Cancer Res; 2011 Aug; 17(16):5432-42. PubMed ID: 21715568
[TBL] [Abstract][Full Text] [Related]
29. Antrodia salmonea induces G
Chang CT; Hseu YC; Thiyagarajan V; Huang HC; Hsu LS; Huang PJ; Liu JY; Liao JW; Yang HL
J Ethnopharmacol; 2017 Jan; 196():9-19. PubMed ID: 27986611
[TBL] [Abstract][Full Text] [Related]
30. Selective, nontoxic CB(2) cannabinoid o-quinone with in vivo activity against triple-negative breast cancer.
Morales P; Blasco-Benito S; Andradas C; Gómez-Cañas M; Flores JM; Goya P; Fernández-Ruiz J; Sánchez C; Jagerovic N
J Med Chem; 2015 Mar; 58(5):2256-64. PubMed ID: 25671648
[TBL] [Abstract][Full Text] [Related]
31. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
Takai K; Le A; Weaver VM; Werb Z
Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
[TBL] [Abstract][Full Text] [Related]
32. Clathrin-mediated endocytic uptake of PUFA enriched self-nanoemulsifying lipidic systems (SNELS) of an anticancer drug against triple negative cancer and DMBA induced preclinical tumor model.
Khurana RK; Kumar R; Gaspar BL; Welsby G; Welsby P; Kesharwani P; Katare OP; Singh KK; Singh B
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():645-658. PubMed ID: 30033299
[TBL] [Abstract][Full Text] [Related]
33. The trans-[Ru(PPh
Becceneri AB; Popolin CP; Plutin AM; Maistro EL; Castellano EE; Batista AA; Cominetti MR
J Inorg Biochem; 2018 Sep; 186():70-84. PubMed ID: 29857173
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic targeting of casein kinase 1δ in breast cancer.
Rosenberg LH; Lafitte M; Quereda V; Grant W; Chen W; Bibian M; Noguchi Y; Fallahi M; Yang C; Chang JC; Roush WR; Cleveland JL; Duckett DR
Sci Transl Med; 2015 Dec; 7(318):318ra202. PubMed ID: 26676609
[TBL] [Abstract][Full Text] [Related]
35. Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity.
Shahin M; Soudy R; Aliabadi HM; Kneteman N; Kaur K; Lavasanifar A
Biomaterials; 2013 May; 34(16):4089-4097. PubMed ID: 23465829
[TBL] [Abstract][Full Text] [Related]
36. Plasma membrane targeting by short chain sphingolipids inserted in liposomes improves anti-tumor activity of mitoxantrone in an orthotopic breast carcinoma xenograft model.
Cordeiro Pedrosa LR; van Tellingen O; Soullié T; Seynhaeve AL; Eggermont AM; Ten Hagen TL; Verheij M; Koning GA
Eur J Pharm Biopharm; 2015 Aug; 94():207-19. PubMed ID: 25982691
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antiproliferative activity of novobiocin analogues as potential hsp90 inhibitors.
Audisio D; Methy-Gonnot D; Radanyi C; Renoir JM; Denis S; Sauvage F; Vergnaud-Gauduchon J; Brion JD; Messaoudi S; Alami M
Eur J Med Chem; 2014 Aug; 83():498-507. PubMed ID: 24992077
[TBL] [Abstract][Full Text] [Related]
38. Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo.
Garcia D; Nasarre P; Bonilla IV; Hilliard E; Peterson YK; Spruill L; Broome AM; Hill EG; Yustein JT; Mehrotra S; Klauber-DeMore N
Ann Surg Oncol; 2019 Dec; 26(13):4782-4790. PubMed ID: 31515721
[TBL] [Abstract][Full Text] [Related]
39. The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells.
Salem I; Alsalahi M; Chervoneva I; Aburto LD; Addya S; Ott GR; Ruggeri BA; Cristofanilli M; Fernandez SV
Breast Cancer Res; 2016 Mar; 18(1):37. PubMed ID: 27009091
[TBL] [Abstract][Full Text] [Related]
40. Rutin as A Novel c-Met Inhibitory Lead for The Control of Triple Negative Breast Malignancies.
Elsayed HE; Ebrahim HY; Mohyeldin MM; Siddique AB; Kamal AM; Haggag EG; El Sayed KA
Nutr Cancer; 2017; 69(8):1256-1271. PubMed ID: 29083228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
